Center for Diabetes & Metabolic Diseases Pilot & Feasibility Grant: Category 1
Indiana Clinical and Translational Sciences Institute (CTSI)
Funding Amount
Up to US $50,000
Deadline
Deadline not published
Grant Type
Foundation
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Must be independent investigators with necessary resources for proposed research
- These funding opportunities invite applications from investigators at Indiana University School of Medicine and other Indiana University campuses (IU Bloomington, IU Muncie, etc.), Purdue University, University of Notre Dame and the Indiana Biomedical Research Institute (IBRI).
Other requirements
- All eligible investigators must have faculty appointments, be independent investigators and have the education, skills, knowledge, and resources necessary to carry out the proposed research.
- Work supported by these funds is expected to lead to submissions of major extramural grants (R01/equivalent NIH, major foundation awards, DOD, etc.)National and international collaborations are allowed.
- New investigators, as defined by the NIH, should not have previously competed successfully for a substantial (e.g., R01) NIH-supported independent research award.
Not eligible / not funded
- Not eligible: Postdoctoral fellows or their equivalent are not eligible.
- Not eligible: Travel to conferences or seminars are not an allowable expense.
- Not eligible: Budget requests may not include indirect costs, F&A, or PI salaries.
Overview
The Center for Diabetes & Metabolic Diseases offers a Pilot & Feasibility Grant aimed at fostering new diabetes-related researchers and supporting innovative, high-risk projects. This grant, up to $50,000 for one year, is directed to new investigators without prior NIH support. It promotes interdisciplinary collaboration among Indiana University campuses and encourages applications that may lead to significant extramural funding. Eligible applicants must be independent investigators with necessary resources for proposed research.
Center for Diabetes & Metabolic Diseases Pilot & Feasibility Grant
A primary research-related activity of the Center for Diabetes and Metabolic Diseases (CDMD)’s Pilot and Feasibility (P&F) program is to foster the development of new diabetes-related investigators and provide seed-support for innovative, high-risk projects.
The CDMD P&F program has three different grant mechanisms:
Parent P&F Grants: This mechanism invites applications directed towards basic biomedical, clinical, and/or translational research questions on cellular and molecular metabolism related to diabetes/obesity/metabolic syndrome, clinical and outcomes research in diabetes and obesity, complications of diabetes and obesity, islet function and survival, and nutrition and physiology of diabetes and obesity.
Alzheimer’s-Focused P&F Grants: This mechanism invites applications focused on diabetes and metabolic disease aspects of Alzheimer’s disease and its related dementias (AD/ADRD)–frontotemporal dementia, Lewy body dementia, vascular cognitive impairment with dementia, and multiple etiology dementias.
Physician-Scientist P&F Grants: This mechanism invites applications from exceptional emerging physician-scientists holding an MD (or equivalent) or MD/PhD with a patient-oriented diabetes and/or obesity-related clinical research project, who are early in their clinical research careers and show great promise to develop into future independent investigators.
New investigators without current or past NIH research support as a PD/PI with any current or past support from other sources being modest
Awards are up to $50,000 for one year
Travel budget requested must be limited to those expenses necessary to carry out the specific aims of the proposed project.Graduate student stipends (only) are an allowable expense.
Publication fees are deemed an allowable expense.
Eligibility
All eligible investigators must have faculty appointments, be independent investigators and have the education, skills, knowledge, and resources necessary to carry out the proposed research. These funding opportunities invite applications from investigators at Indiana University School of Medicine and other Indiana University campuses (IU Bloomington, IU Muncie, etc.), Purdue University, University of Notre Dame and the Indiana Biomedical Research Institute (IBRI).Work supported by these funds is expected to lead to submissions of major extramural grants (R01/equivalent NIH, major foundation awards, DOD, etc.)National and international collaborations are allowed.New investigators, as defined by the NIH, should not have previously competed successfully for a substantial (e.g., R01) NIH-supported independent research award.
Ineligibility
Postdoctoral fellows or their equivalent are not eligible.Travel to conferences or seminars are not an allowable expense.Budget requests may not include indirect costs, F&A, or PI salaries.
Focus Areas & Funding Uses
Fields of Work
- Science research
- Alzheimer's
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Stark Neurosciences- Pre-Clinical Neuroimaging Pilot Grant: Category 1
Indiana Clinical and Translational Sciences Institute (CTSI)
Amount
Up to US $10,000
Deadline
Deadline not published
Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
November 10, 2026
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
National Institutes of Health
Amount
Varies
Deadline
November 19, 2026
Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Up to $1,000,000
Deadline
May 7, 2028
Parkinson's Disease Therapeutics Pipeline Grant Program
The Michael J Fox Foundation for Parkinson's Research
Amount
US $250,000 - US $2,000,000
Deadline
October 30, 2026
Listed date — confirm with the funder
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
National Institutes of Health
Amount
Up to $1,500,000
Deadline
November 5, 2027
Ready to apply for Center for Diabetes & Metabolic Diseases Pilot & Feasibility Grant: Category 1?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Center for Diabetes & Metabolic Diseases Pilot & Feasibility Grant: Category 1. Now let's win it.